News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BUCHI J KEVIN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Bought 51,813 shares
@ $0
Bought 51,813 options to buy
@ $3.86, valued at
$200k
|
|
| 06/09/2023 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.|
Txns:
| Bought 25,000 shares
@ $0.296, valued at
$7.4k
|
|
| 05/17/2023 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.|
Txns:
| Bought 32,534 shares
@ $0.2743, valued at
$8.9k
|
|
| 05/11/2023 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 35,406 restricted stock units
@ $0
Granted 80,128 restricted stock units
@ $0 |
|
| 01/03/2022 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options to buy
@ $0.56, valued at
$42k
|
|
| 12/29/2021 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 4,666 shares
@ $38.25, valued at
$178.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 8,000 options to buy
@ $14.13, valued at
$113k
Disposed/sold 25,000 options to buy
@ $14.76, valued at
$369k
Disposed/sold 33,000 options to buy
@ $15.44, valued at
$509.5k
Disposed/sold 21,000 options to buy
@ $21.61, valued at
$453.8k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/10/2021 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Granted 12,000 options to buy
@ $2.99, valued at
$35.9k
|
|
| 10/25/2021 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.67, valued at
$250.5k
|
|
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 35,406 restricted stock units
@ $0
Exercised 46,218 restricted stock units
@ $0 |
|
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2020 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Granted 23,601 options to buy
@ $2.98, valued at
$70.3k
|
|
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 4,666 restricted stock units
@ $0
Granted 21,000 options to buy
@ $21.61, valued at
$453.8k
|
|
| 05/07/2020 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 46,218 restricted stock units
@ $0
Exercised 6,459 restricted stock units
@ $0 |
|
| 10/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 33,000 options to buy
@ $15.44, valued at
$509.5k
|
|
| 05/08/2019 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 28,044 options
@ $14.05, valued at
$394k
Granted 6,459 restricted stock units
@ $0
Exercised 6,107 restricted stock units
@ $0 |
|
| 03/29/2019 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 8,000 options to buy
@ $14.13, valued at
$113k
|
|
| 08/15/2018 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 25,000 options to buy
@ $14.76, valued at
$369k
|
|
| 05/08/2018 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 11,301 shares
@ $0
Granted 7,931 options
@ $16.4, valued at
$130.1k
Granted 20,445 options
@ $14.45, valued at
$295.4k
Granted 24,977 options
@ $15.01, valued at
$374.9k
Granted 6,107 restricted stock units
@ $0 |
|
| 05/08/2018 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 8,020 shares
@ $0
Disposed/sold 3,281 shares
@ $0
Disposed/sold 7,931 options to buy
@ $16.4, valued at
$130.1k
Disposed/sold 20,445 options to buy
@ $14.45, valued at
$295.4k
|
|
| 05/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/25/2015 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 24,000 options to buy
@ $12.76, valued at
$306.2k
|
|
| 06/25/2015 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 12,500 options to buy
@ $1.28, valued at
$16k
Granted 12,500 options to buy
@ $1.28, valued at
$16k
|
|
| 06/08/2015 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 9,000 options to buy
@ $6.39, valued at
$57.5k
|
|
| 03/30/2015 |
4
| BUCHI J KEVIN (President & CEO) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Bought 5,000 shares
@ $4.2295, valued at
$21.1k
|
|
| 01/30/2015 |
4
| BUCHI J KEVIN (President & CEO) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 200,000 options
@ $5.25, valued at
$1.1M
Granted 150,000 restricted stock units
@ $0 |
|
| 01/09/2015 |
4
| BUCHI J KEVIN (President & CEO) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Bought 5,000 shares
@ $5.0362, valued at
$25.2k
|
|
| 12/11/2014 |
4
| BUCHI J KEVIN (President & CEO) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Bought 5,000 shares
@ $6.012, valued at
$30.1k
|
|
|
|
|